Table 2

Summary of outcome measures and assessment instruments

OutcomeAssessment instrumentWeek 0
(baseline)
Week 6 (intermediate)Week 12 (endline)Week 24 (follow-up)
Primary outcome
Cognitive functionADAS-Cog++++
CSI-D++++
Secondary outcome
ADL++++
EQ-5D-5L++++
PSQI++++
Intrinsic capacityMNA-SF++++
SPPB++++
PHQ-9++++
Sensory: vision and hearing++++
FrailtyFP++++
IPAQ-SF++++
Social supportLSNS++++
Healthcare utilisation and costNumber of outpatient and inpatient visits++
Outpatient, inpatient and self-medication costs++
Process evaluation
Eligibility and recruitmentRetention rate and reasons for withdrawal++++
Intervention acceptabilityParticipants’ training logs, online monitoring data, supervisory documents, adherence records automatically collected through RehabApp and COGITO programme and satisfaction surveys conducted through qualitative interviews++++
Outcome acceptabilityOutcome questionnaire completion rate++++
Intervention sustainabilityParticipants’ continuing training logs and qualitative interviews+
Adverse eventsAdverse events++++
Cost-effectivenessThe indicator is the incremental cost-effectiveness ratio (ICER), which is defined as the difference in intervention costs between the intervention and control groups divided by the difference in intervention outcomes between the two groups.
Cost-benefitThe indicator is the benefit-cost ratio (BCR), which is calculated as the present value of total benefits divided by the present value of total costs.
  • ADAS-Cog, Alzheimer’s Disease Assessment Scale-Cognitive; ADL, Activity Daily of Life; CSI-D, Community Screening Instrument for Dementia; EQ-5D-5L, EuroQol-5D-5L; FP, Frailty Phenotype; IPAQ-SF, International Physical Activity Questionnaire--Short Form; LSNS, Lubben Social Network Scale; MNA-SF, Mini Nutritional Assessment Short-Form; PHQ-9, Patient Health Questionnaire; PSQI, Pittsburgh Sleep Quality Index; SPPB, Short Physical Performance Battery.